Skip to main content
SpringerLink
Log in

Clinical Effectiveness of Lifestyle Management Programs: Importance of the Class Effect Paradox

  • Invited Commentary
  • Published:
Current Treatment Options in Cardiovascular Medicine Aims and scope Submit manuscript

Opinion Statement

It is well appreciated in pharmacotherapy that all drugs belonging to the same class of agents are not necessarily equally safe or effective. Because of this so-called “class effect paradox,” pharmaceutical companies must do extensive research to prove the safety and efficacy of a new drug before introducing it into the market, even if it belongs to a well-established class of medications. Like pharmaceutical agents, lifestyle management interventions can be organized into classes. This commentary examines the rationale for, and importance of, considering the class effect paradox when balancing the need for new and innovative lifestyle management programs with the need for evidence-based interventions with proven outcomes. In view of the fact that all lifestyle management programs within a specific broad intervention class do not necessarily result in clinical benefit, it is recommended that any new approach should not be widely implemented until it has been shown to be effective as evidenced by results of clinical studies published in peer-reviewed journals.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and recommended reading

  1. Roberts CK, Barnard RJ. Effects of exercise and diet on chronic disease. J Appl Physiol. 2005;78:3–30.

    Google Scholar 

  2. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics—2013 update: a report from the American Heart Association. Circulation. 2013;127:e6–e245.

    Article  PubMed  Google Scholar 

  3. Mayosi BM, Flisher AJ, Lalloo UG, Sitas F, Tollman SM, Bradshaw D. The burden of non-communicable diseases in South Africa. Lancet. 2009;374:934–47.

    Article  PubMed  Google Scholar 

  4. Shay CM, Ning H, Allen NB, Carnethon MR, Chiuve SE, Greenlund KJ, et al. Status of cardiovascular health in US adults: prevalence estimates from the National Health and Nutrition Examination Surveys (NHANES) 2003–2008. Circulation. 2012;125:45–56.

    Article  PubMed  Google Scholar 

  5. Mattke S, Liu H, Caloyeras JP, Huang CY, Van Busum KR, Khodyakov D, et al. Workplace wellness programs study final report. Santa Monica: RAND Corporation; 2013.

    Google Scholar 

  6. Maron DJ, Forbes BL, Groves JR, Dietrich MS, Sells P, DiGenio AG. Health-risk appraisal with or without disease management for worksite cardiovascular risk reduction. J Cardiovasc Nurs. 2008;23:513–8.

    Article  PubMed  Google Scholar 

  7. Lin JS, O’Connor E, Whitlock EP, Beil TL, Zuber SP, Perdue LA, et al. Behavioral counseling to promote physical activity and a healthful diet to prevent cardiovascular disease in adults: update of the evidence for the US Preventive Services Task Force. Evidence synthesis no. 79. AHRQ publication no. 11-05149-EF-1. Rockville, MD, December 2010.

  8. US Preventive Services Task Force. Behavioral counseling interventions to promote a healthful diet and physical activity for cardiovascular disease prevention in adults: clinical summary of US Preventive Services Task Force Recommendation. AHRQ publication no. 11-05149-EF-3, June 2012.

  9. Balady GJ, Ades PA, Bittner VA, Franklin BA, Gordon NF, Thomas RJ, et al. Referral, enrollment and delivery of cardiac rehabilitation/secondary prevention programs at clinical centers and beyond: a Presidential Advisory from the American Heart Association. Circulation. 2011;124:2951–60.

    Article  PubMed  Google Scholar 

  10. The Look AHEAD Research Group. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;369:145–54.

    Article  Google Scholar 

  11. Gerstein HC. Do lifestyle changes reduce serious outcomes in diabetes? N Engl J Med. 2013;369:189–90.

    Article  PubMed  CAS  Google Scholar 

Download references

Compliance with ethics guidelines

Conflict of Interest

Dr. Neil F. Gordon has received consultancies from Wellness Corporate Solutions, LLC and PrevCan, Inc., and serves as a board member for PrevCan, Inc. Dr. Gordon is employed by and holds stock/stock options with Intervent International, LLC. Dr. Gordon holds stock/stock options with PrevCan, Inc.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. INTERVENT International, 340 Eisenhower Drive, Building 1400, Suite 17, Savannah, GA, 31406, USA

    Neil F. Gordon MD, PhD, MPH, FACC

Authors
  1. Neil F. Gordon MD, PhD, MPH, FACC
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Neil F. Gordon MD, PhD, MPH, FACC.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gordon, N.F. Clinical Effectiveness of Lifestyle Management Programs: Importance of the Class Effect Paradox. Curr Treat Options Cardio Med 15, 675–680 (2013). https://doi.org/10.1007/s11936-013-0271-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11936-013-0271-4

Keywords

Search

Navigation